Vimarsana
Biggest News Aggregation in the World

Cellular Plasticity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cellular Plasticity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cellular Plasticity Today - Breaking & Trending Today

Study establishes iron accumulation as a driver of pathological senescence and fibrosis - Vimarsana News

Study establishes iron accumulation as a driver of pathological senescence and fibrosis

Fibrosis is associated with various chronic and life-threatening conditions, including pulmonary fibrosis, liver cirrhosis, kidney disease, and cardiovascular diseases, among others.

Medication for heart conditions improves melanoma treatment - Vimarsana News

Medication for heart conditions improves melanoma treatment

Administration of ranolazine, a drug currently used to treat heart conditions, improves the efficacy of current therapies for melanoma in mouse models of the disease.

Senescent Cell "Vaccine" Reduces Tumor Development in Cancer Models - Vimarsana News

Senescent Cell "Vaccine" Reduces Tumor Development in Cancer Models

Researchers have used senescent cells as a "vaccine" that can be used as a prophylaxis and a therapeutic to prime the immune system against cancer cells, which has shown positive results in cancer models.

Senescent cells as vaccines against cancer - Vimarsana News

Senescent cells as vaccines against cancer

• Researchers at IRB Barcelona report that the induction of senescence in tumour cells strongly stimulates the immune system. • Vaccination with sene....

Vaccination with senescent cells could be a possible therapy against cancer - Vimarsana News

Vaccination with senescent cells could be a possible therapy against cancer

Cancer cells have a series of features that allow the immune system to identify and attack them. However, these same cells create an environment that blocks immune cells and protects the tumor.